Liu et al. showed that H19 could regulated the development of cardiac hypertrophy through miR-675/CaMKIIδ pathway26, indicating that dysregulation of H19 may also contribute to the pathogenesis of ischemic heart failure. This evidence concerns the gene H19 and cardiac hypertrophy.